Identification of patients at high risk of malignant ventricular arrhythmias by means of using QRST integral mapping

1990 ◽  
Vol 23 (3) ◽  
pp. 280
Author(s):  
R. Hatala ◽  
A. Voss ◽  
H.J. Kleiner ◽  
M. Tysler ◽  
M. Maco ◽  
...  
2005 ◽  
Vol 14 (4) ◽  
pp. 294-303 ◽  
Author(s):  
Sandra B. Dunbar

Use of implantable cardioverter defibrillators has become standard therapy for patients at high risk for life-threatening ventricular arrhythmias. Although acceptance of the device is generally high among patients and their families, quality of life and psychosocial issues associated with use of the defibrillators deserve greater attention to improve outcomes. Psychosocial issues, their ramifications, and theory-and evidence-based approaches to improving outcomes are described.


Heart ◽  
1976 ◽  
Vol 38 (10) ◽  
pp. 1053-1057 ◽  
Author(s):  
R W Campbell ◽  
M G Godman ◽  
G I Fiddler ◽  
R M Marquis ◽  
D G Julian

2006 ◽  
Vol 97 (3) ◽  
pp. 416-420 ◽  
Author(s):  
Robert S. Phang ◽  
David Kang ◽  
Hocine Tighiouart ◽  
N.A. Mark Estes ◽  
Mark S. Link

2015 ◽  
Vol 04 (2) ◽  
pp. 96 ◽  
Author(s):  
Manoj N Obeyesekere ◽  
Andrew D Krahn ◽  
◽  

The early repolarisation (ER) pattern is a common ECG finding. Most individuals with the ER pattern are at minimal risk for arrhythmic events. In others, ER increases the arrhythmic risk of underlying cardiac pathology. Rarely ER syndrome will manifest as a primary arrhythmogenic disorder causing ventricular fibrillation (VF). ER syndrome is defined as syncope attributed to ventricular arrhythmias or cardiac arrest attributed to ER following systematic exclusion of other etiologies. Some ECG features associated with ER portend a higher risk. However, clinically useful risk-stratifying tools to identify the asymptomatic patient at high risk are lacking. Patients with asymptomatic ER and no family history of malignant ER should be reassured. All patients with ER should continue to have modifiable cardiac risk factors addressed. Symptomatic patients should be systematically investigated, directed by symptoms.


2020 ◽  
Vol 9 (3) ◽  
pp. 848
Author(s):  
Laurent Rosier ◽  
Amir Zouaghi ◽  
Valentin Barré ◽  
Raphaël Martins ◽  
Vincent Probst ◽  
...  

Acute myocarditis is associated with cardiac arrhythmia in 25% of cases; a third of these arrhythmias are ventricular tachycardia (VT) or ventricular fibrillation (VF). The implantation of a cardiac defibrillator (ICD) following sustained ventricular arrhythmia remains controversial in these patients. We sought to assess the risk of major arrhythmic ventricular events (MAEs) over time in patients implanted with an ICD following sustained VT/VF in the acute phase of myocarditis compared to those implanted for VT/VF occurring on myocarditis sequelae. Our retrospective observational study included patients implanted with an ICD following VT/VF during acute myocarditis or VT/VF on myocarditis sequelae, from 2007 to 2017, in 15 French university hospitals. Over a median follow-up period of 3 years, MAE occurred in 11 (39%) patients of the acute myocarditis group and 24 (60%) patients of the myocarditis sequelae group. Kaplan–Meier MAE rate estimates at one and three years of follow-up were 19% and 45% in the acute group, and 43% and 64% in the sequelae group. Patients who experienced sustained ventricular arrhythmias during acute myocarditis had a very high risk of VT/VF recurrence during follow-up. These results show that the risk of MAE recurrence remains high after resolution of the acute episode.


2015 ◽  
Vol 65 (6) ◽  
pp. 459-465 ◽  
Author(s):  
Aleksander Araszkiewicz ◽  
Marek Grygier ◽  
Małgorzata Pyda ◽  
Justyna Rajewska ◽  
Maciej Lesiak ◽  
...  

2013 ◽  
Vol 61 (10) ◽  
pp. E255
Author(s):  
Yutthapong Temtanakitpaisan ◽  
David Kopelman ◽  
Ahsanuddin Ahmad ◽  
N.A. Estes ◽  
Mark Link

Sign in / Sign up

Export Citation Format

Share Document